Results 161 to 170 of about 68,419 (288)

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB–IIIB Lung Squamous Cell Carcinoma

open access: yesMedComm, Volume 7, Issue 7, July 2026.
This phase II trial suggests the potential of perioperative camrelizumab plus neoadjuvant chemotherapy in patients with resectable stage IIB‐IIIB lung squamous cell carcinoma. The major pathological response rate (primary endpoint) was 60.0%, and the pathological complete response (pCR) rate was 44.4%.
Mingming Hu   +17 more
wiley   +1 more source

Mixed-phenotype acute leukemia with trilineage differentiation presenting as a non-leukemic mediastinal tumor. [PDF]

open access: yesJ Clin Exp Hematop
Ichikawa S   +6 more
europepmc   +1 more source

Initial Dose Tarlatamab–Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 7, July 2026.
We report a fatal case of acute TLS following a single 1‐mg dose of tarlatamab in a patient with relapsed SCLC with extensive liver metastases. This case highlights the importance of TLS risk assessment prior to tarlatamab treatment. Extensive liver metastases and elevated lactate dehydrogenase levels may be risk factors for TLS in patients with SCLC ...
Katsuhiko Shibata   +8 more
wiley   +1 more source

Clinical Remission of an Unresectable Presumptive Haemangiosarcoma in a Dog Treated With Toceranib, Piroxicam, and Propranolol: A Case Report

open access: yesVeterinary Medicine and Science, Volume 12, Issue 4, July 2026.
Radiographic remission of a presumptive unresectable haemangiosarcoma treated with toceranib, piroxicam, and propranolol. In a dog with ACVIM Stage B2 myxomatous mitral valve disease where doxorubicin‐based chemotherapy was contraindicated, this multimodal regimen achieved marked tumour reduction and radiographic disappearance.
Woo Dae Park
wiley   +1 more source

Multi-Level Oncological Management of a Rare, Combined Mediastinal Tumor: A Case Report. [PDF]

open access: yesCurr Oncol
Theocharidis V   +14 more
europepmc   +1 more source

Anterior mediastinal tumor surgery applying single-port thoracoscopy using the subxiphoid approach. [PDF]

open access: yesTurk Gogus Kalp Damar Cerrahisi Derg, 2023
Chen H   +5 more
europepmc   +1 more source

A Young Adult of Mediastinal Carcinoid Tumor

open access: yes, 1998
症例は29歳男性,嗄声で発症し,検診の胸部X線で縦隔腫瘍を指摘され,左鎖骨上窩リンパ節生検によりカルチノイドと診断した.腫瘍は大血管を巻き込んで手術不能であり,生検組織を用いた抗癌剤感受性試験でも各種抗癌剤に対し耐性を示した.しかし3コースの化学療法と合計55Gyの胸部放射線同時照射を施行し,若干の効果が認められ,治療開始より18ヵ月経過した現在も腫瘍増大,症状増悪なく外来通院中である.進行型カルチノイドに対する治療法開発の必要性を感じた.A 29-year-old man was admitted ...
井上, 啓爾   +5 more
core  

Lobe‐Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non‐Small Cell Lung Cancer: A Propensity Score‐Matched Analysis Based on the 8th Edition of the TNM Stage Classification

open access: yesThoracic Cancer, Volume 17, Issue 13, July 2026.
In this propensity score‐matched study of clinical stage I non‐small cell lung cancer, lobe‐specific lymph node dissection achieved comparable overall and relapse‐free survival to systematic lymph node dissection while reducing operative invasiveness and postoperative supraventricular tachyarrhythmia.
Hirotsugu Notsuda   +11 more
wiley   +1 more source

Resection of a Giant Middle Mediastinal Tumor Using a Transaortopulmonary Arterial Approach. [PDF]

open access: yesAnn Thorac Surg Short Rep
Yano K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy